National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Hodgkin Lymphoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 02/14/2008
Table 2: Sample Definitions of Sites and Corresponding Radiation Treatment Fieldsa

Involved Node(s)  Radiation Field 
Cervical Neck and Infraclavicular/Supraclavicularb
Supraclavicular Neck and Infraclavicular/Supraclavicular ± Axilla
Axilla Axilla ± Infraclavicular/Supraclavicular
Mediastinum Mediastinum, Hila, Infraclavicular/Supraclavicularb,c
Hila Hila, Mediastinum
Spleen Spleen ± Para-aortics
Para-aortics Para-aortics ± Spleen
Iliac Ipsilateral Iliac ± Inguinal + Femoral
Inguinal Inguinal + Femoral ± Iliac
Femoral Inguinal + Femoral ± Iliac

a Adapted from Hudson [24]
b Upper cervical region not treated if supraclavicular involvement is extension of the mediastinal disease.
c Prechemotherapy volume is treated except for lateral borders of the mediastinal field, which is postchemotherapy.

References

  1. Hudson M, Constine LS: Hodgkin's disease. In: Halperin EC, Constine LS, Tarbell NJ, et al.: Pediatric Radiation Oncology. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2004, pp 223-60. 


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov